Caraway Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Caraway Therapeutics's estimated annual revenue is currently $2.8M per year.
- Caraway Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Caraway Therapeutics has 18 Employees.
- Caraway Therapeutics grew their employee count by -47% last year.
Caraway Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Senior Director Chemistry | Reveal Email/Phone |
3 | Senior Director Biology | Reveal Email/Phone |
4 | Director Finance | Reveal Email/Phone |
5 | Director Biology | Reveal Email/Phone |
6 | Associate Director, Corporate Development | Reveal Email/Phone |
7 | Director Biomarker Research | Reveal Email/Phone |
8 | Associate Director Operations & Executive Administration | Reveal Email/Phone |
9 | Laboratory Operations Manager | Reveal Email/Phone |
10 | Senior Manager, HTS Electrophysiology | Reveal Email/Phone |
Caraway Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Caraway Therapeutics?
Caraway's targeted approaches leverage genetic data and unique biological understanding to develop small molecules that activate neurons' clearance and recycling processes – accelerating removal of toxic materials and defective cellular components. New insights in genetics highlight the link between lysosomal processes that normally maintain order inside neurons, and the risk of deterioration that occurs in neurodegenerative diseases. Caraway is a leader in targeting these mechanisms with potentially disease-modifying compounds for patients suffering the devastating effects of neurodegenerative disease including Parkinson's Disease, Amyotrophic Lateral Sclerosis (ALS) and lysosomal storage diseases.
keywords:N/A
N/A
Total Funding
18
Number of Employees
$2.8M
Revenue (est)
-47%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Caraway Therapeutics News
... Captor Therapeutics; Caraway Therapeutics; Casma Therapeutics; Celeris Therapeutics; Centessa Pharmaceuticals; Coho Therapeutics...
Lucy Therapeutics (LucyTx), a biotech with a unifying ... serves on the Scientific Advisory Board of Caraway Therapeutics and Medtronic.
Caraway Therapeutics is a biopharmaceutical company pursuing novel approaches for the treatment of genetically defined neurodegenerative and...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.1M | 18 | -10% | $161M |
#2 | $3.5M | 18 | N/A | N/A |
#3 | $1.6M | 18 | N/A | N/A |
#4 | $2.5M | 18 | -14% | N/A |
#5 | $3.5M | 18 | -40% | N/A |